The data from medicine prices surveys conducted in 9 countries (Jordan, Kuwait, Lebanon, Morocco, Pakistan, Sudan [Khartoum State], Syrian Arab Republic, Tunisia and Yemen) of the Eastern Mediterranean Region and utilizing the WHO/HAI methodology are summarized in this report. These countries differ in demographic and economic indicators as well as health system structures and pharmaceutical policies. Within this diversity, the results are compared to investigate common elements and lessons for pharmaceutical policy review and implementation which can be learnt from sharing and comparing experiences.